Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Bioavailability and Dosing of a Monosaccharide Supplement in Adults
This study is ongoing, but not recruiting participants.
Sponsors and Collaborators: Arkansas Children's Hospital Research Institute
University of Arkansas
United States Department of Agriculture
Information provided by: Arkansas Children's Hospital Research Institute
ClinicalTrials.gov Identifier: NCT00782392
  Purpose

We are developing an oral supplement of carbohydrates to be added to infant formulas in order to improve brain development, immune function, and overall health of infants and children. After a careful review of what is known about these sugars, there is very little information regarding their use in infants and children, although there is some information in adults and animals.

Many of these sugars have been used in a glyconutritional supplement in adults and children, with minimal or no reported side effects.

We are developing a custom blend of important individual sugars, and need information regarding their dosing and blood concentrations following oral intake of the carbohydrate supplement. Timed blood samples following the carbohydrate supplement will provide us with a better understanding of the most effective dose and the metabolism of these sugars in adults. This will give us the preliminary information we need for developing an oral supplement of special sugars that can be added to infant formulas to help improve brain development and immune function in infants and children.


Condition
Healthy Males

MedlinePlus related topics: Dietary Supplements Infant and Toddler Nutrition
U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Cross-Sectional
Official Title: Bioavailability and Dosing of an Oral Monosaccharide Supplement in Adults and Effects on Resting Brain Activity

Further study details as provided by Arkansas Children's Hospital Research Institute:

Biospecimen Retention:   Samples Without DNA

Biospecimen Description:

Plasma


Enrollment: 15
Study Start Date: January 2007
Estimated Study Completion Date: June 2009
Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 28 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Healthy Caucasion Males

Criteria

Inclusion Criteria:

  • Caucasion (non-hispanic)
  • Male
  • Age 18-28
  • Regularly eat breakfast
  • Healthy
  • BMI within normal limits (18.5 - 24.9)
  • English speaking

Exclusion Criteria:

  • History of smoking, more than occasional alcohol use, or drug use.
  • Chronic medical diagnosis
  • Medicatinos that may interefere with the study
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00782392

Locations
United States, Arkansas
Arkansas Children's Nutrition Center
Little Rock, Arkansas, United States, 72202
Sponsors and Collaborators
Arkansas Children's Hospital Research Institute
University of Arkansas
United States Department of Agriculture
  More Information

Responsible Party: University of Arkansas for Medical Sciences ( Joanne S. Szabo, M.D. )
Study ID Numbers: 45092
Study First Received: October 29, 2008
Last Updated: October 29, 2008
ClinicalTrials.gov Identifier: NCT00782392  
Health Authority: United States: Institutional Review Board

Keywords provided by Arkansas Children's Hospital Research Institute:
Nutrition
Infant Formula

Study placed in the following topic categories:
Healthy

ClinicalTrials.gov processed this record on January 16, 2009